Time-series RNA-seq analysis reveals dynamic transcriptional responses and crosstalk in chronic lymphocytic leukaemia (CLL) autologous and monoculture in vitro models
RNA-seq (gene expression) · human · 60 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Chronic lymphocytic leukemiaThis series is part of our curated briefing on it.
- Samples
- 60 samples: 30 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE313098_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1378255 and SRA study SRP653846. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 60 samples.
How we read this: 30 replicated groups read from 60 sample titles; they account for 60 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9360838 DAR Day 1 autologous PBMC culture replicate 1 DAR Day 1 autologous PB…
- GSM9360839 DAR Day 1 autologous PBMC culture replicate 2 DAR Day 1 autologous PB…
- GSM9360840 DAR Day 1 CLL B-cell monoculture replicate 1 DAR Day 1 CLL B-cell mo…
- GSM9360841 DAR Day 1 CLL B-cell monoculture replicate 2 DAR Day 1 CLL B-cell mo…
- GSM9360842 DAR Day 4 autologous PBMC culture replicate 1 DAR Day 4 autologous PB…
- GSM9360843 DAR Day 4 autologous PBMC culture replicate 2 DAR Day 4 autologous PB…
- GSM9360844 DAR Day 4 CLL B-cell monoculture replicate 1 DAR Day 4 CLL B-cell mo…
- GSM9360845 DAR Day 4 CLL B-cell monoculture replicate 2 DAR Day 4 CLL B-cell mo…
- GSM9360846 DAR Day 8 autologous PBMC culture replicate 1 DAR Day 8 autologous PB…
- GSM9360847 DAR Day 8 autologous PBMC culture replicate 2 DAR Day 8 autologous PB…
- GSM9360848 DAR Day 8 CLL B-cell monoculture replicate 1 DAR Day 8 CLL B-cell mo…
- GSM9360849 DAR Day 8 CLL B-cell monoculture replicate 2 DAR Day 8 CLL B-cell mo…
- GSM9360850 DAR Day 11 autologous PBMC culture replicate 1 DAR Day 11 autologous P…
- GSM9360851 DAR Day 11 autologous PBMC culture replicate 2 DAR Day 11 autologous P…
- GSM9360852 DAR Day 11 CLL B-cell monoculture replicate 1 DAR Day 11 CLL B-cell m…
- GSM9360853 DAR Day 11 CLL B-cell monoculture replicate 2 DAR Day 11 CLL B-cell m…
- GSM9360854 DAR Day 14 autologous PBMC culture replicate 1 DAR Day 14 autologous P…
- GSM9360855 DAR Day 14 autologous PBMC culture replicate 2 DAR Day 14 autologous P…
- GSM9360856 DAR Day 14 CLL B-cell monoculture replicate 1 DAR Day 14 CLL B-cell m…
- GSM9360857 DAR Day 14 CLL B-cell monoculture replicate 2 DAR Day 14 CLL B-cell m…
- GSM9360858 SAS Day 1 autologous PBMC culture replicate 1 SAS Day 1 autologous PB…
- GSM9360859 SAS Day 1 autologous PBMC culture replicate 2 SAS Day 1 autologous PB…
- GSM9360860 SAS Day 1 CLL B-cell monoculture replicate 1 SAS Day 1 CLL B-cell mo…
- GSM9360861 SAS Day 1 CLL B-cell monoculture replicate 2 SAS Day 1 CLL B-cell mo…
- GSM9360862 SAS Day 4 autologous PBMC culture replicate 1 SAS Day 4 autologous PB…
- GSM9360863 SAS Day 4 autologous PBMC culture replicate 2 SAS Day 4 autologous PB…
- GSM9360864 SAS Day 4 CLL B-cell monoculture replicate 1 SAS Day 4 CLL B-cell mo…
- GSM9360865 SAS Day 4 CLL B-cell monoculture replicate 2 SAS Day 4 CLL B-cell mo…
- GSM9360866 SAS Day 8 autologous PBMC culture replicate 1 SAS Day 8 autologous PB…
- GSM9360867 SAS Day 8 autologous PBMC culture replicate 2 SAS Day 8 autologous PB…
- GSM9360868 SAS Day 8 CLL B-cell monoculture replicate 1 SAS Day 8 CLL B-cell mo…
- GSM9360869 SAS Day 8 CLL B-cell monoculture replicate 2 SAS Day 8 CLL B-cell mo…
- GSM9360870 SAS Day 11 autologous PBMC culture replicate 1 SAS Day 11 autologous P…
- GSM9360871 SAS Day 11 autologous PBMC culture replicate 2 SAS Day 11 autologous P…
- GSM9360872 SAS Day 11 CLL B-cell monoculture replicate 1 SAS Day 11 CLL B-cell m…
- GSM9360873 SAS Day 11 CLL B-cell monoculture replicate 2 SAS Day 11 CLL B-cell m…
- GSM9360874 SAS Day 14 autologous PBMC culture replicate 1 SAS Day 14 autologous P…
- GSM9360875 SAS Day 14 autologous PBMC culture replicate 2 SAS Day 14 autologous P…
- GSM9360876 SAS Day 14 CLL B-cell monoculture replicate 1 SAS Day 14 CLL B-cell m…
- GSM9360877 SAS Day 14 CLL B-cell monoculture replicate 2 SAS Day 14 CLL B-cell m…
+ 20 more — browse all 60 samples with per-sample file links →
- GSE305855 Casein kinase 1δ/ε inhibition suppresses CLL through cell-intrinsic and microenvironmental mechanisms [RNA-Seq] 42 samples same disease briefing · shares cll, rna-seq
- GSE264554 CD40 stimulation + dasatinib treatment of chronic lymphocytic leukemia (CLL) cells 3 samples same disease briefing · shares cll, lymphocytic
- GSE311112 Single-cell RNA-seq analysis reveals distinct tumor and immunosuppressive T-cell phenotypes in CLL patients treated with ibrutinib 105 samples same disease briefing · shares cll, rna-seq
- GSE21029 The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (CLL) 62 samples same disease briefing · shares cll, lymphocytic
- GSE249956 Trascriptional profiling of proliferating and resting fracntions in ibrutinib-treated CLL 40 samples same disease briefing · shares cll
- GSE319429 Defining the acute BTK-loss transcriptional program in CLL using a BTK degrader 32 samples same disease briefing · shares cll
- GSE293100 Modulation of NOTCH1 signaling in CLL and MCL cell lines 30 samples same disease briefing · shares cll
- GSE283397 Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab [scRNA-seq, scTCR-seq and bulk RNA-seq] 15 samples same disease briefing · shares lymphocytic, rna-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.